cytarabine

It is used for the treatment of acute myeloid leukemia (a type of white blood cell cancer) in adults and children, and for other types of leukemia when previous treatments have not been effective.

Form: solution for injection, powder and solvent

ATC: L01BC01

Manufacturer: PFIZER ITALIA S.R.L.

It is used in adults and children for the treatment of acute leukemias (a type of blood cancer characterized by an excess of white blood cells). The drug can be used for induction of remission (an intensive treatment to try to normalize the blood cell count) or as maintenance therapy (lower doses to make the remission last as long as possible).

Form: solution for injection

ATC: L01BC01

Manufacturer: ACCORD HEALTHCARE, S.L.U.

It is used for the treatment of a particular type of blood cell cancer called acute myeloid leukemia, in both adults and children. It is also used to induce disease remission by attempting to normalize the balance of cells in the blood, and to treat other diseases characterized by an increase in white blood cells.

Form: solution for injection

ATC: L01BC01

Manufacturer: HIKMA FARMACEUTICA (PORTUGAL) S.A.

It is used for the treatment of patients with a new diagnosis of acute myeloid leukemia, both when caused by previous treatments and when certain alterations are present in the bone marrow.

Form: powder for concentrate for infusion solution

ATC: L01XY01

Manufacturer: JAZZ PHARMACEUTICALS IRELAND LIMITED